Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Jul 13, 2017
    Manufacturer Communication Bills Spark House Panel Debate
  • Jul 13, 2017
    Quiet – Too Quiet – for Advertising and Promotion
  • Jul 6, 2017
    OPDP Research Finds Risk-Benefit Info ‘Not Equally Prominent’ in DTC Mobile Drug Communications
  • Jul 5, 2017
    Allergan Agrees To Pay $13 Million in Qui Tam Case Over Consulting Services
  • Jul 3, 2017
    Two Illinois Counties Sue Companies Over Opioid Marketing
  • Jul 3, 2017
    Missouri Sues Opioid Manufacturers for Fraud
  • Jun 29, 2017
    Nevada Gov. Signs Bill Requiring Sales Rep. Identification and Reporting
  • Jun 20, 2017
    OPDP Research To Examine Risk Info in DTC Print Ads
  • Jun 20, 2017
    GAO Says More FDA and FTC Guidance Needed on Agencies’ Shared Role in Dietary Supplement Oversight
  • Jun 20, 2017
    Senate Bill Introduced Requiring Drug Price Increase Justification
  • More

Good Clinical Practice

  • Dec 15, 2017
    NIH Funds Consortium To Improve Alzheimer Trials
  • Dec 14, 2017
    FDA Plans Workshop on Submitting Draft Guidance on Patient Experience
  • Dec 14, 2017
    Large Survey Finds Fewer People Are ‘Very’ Willing To Participate in Clinical Research
  • Dec 13, 2017
    CDRH Finds Success with EFS Program
  • Dec 11, 2017
    Appeals Court Again Upholds Harkonen Wire Fraud Conviction
  • Dec 11, 2017
    Social Network Survey Finds Patients Need More Trial Education
  • Dec 9, 2017
    Hutchinson Center Receives Determination Letter, But No Violations Found
  • Dec 8, 2017
    Collaboration Looks To Enhance ‘At Home’ Trials
  • Dec 7, 2017
    Most Required Post-Approval Studies Are on Time
  • Dec 7, 2017
    FDA Releases Draft Guidance Suggesting Use of Multi-company Clinical Trials for Rare Diseases
  • More

U.S. Food Labeling

  • Feb 29,2012
    U.S. and EU Sign Equivalence Agreement on Organic Certification and Labeling
  • Feb 29,2012
    Product Recalls
  • Feb 29,2012
    FDA FY 2013 Budget Focuses on Enforcement
  • Feb 29,2012
    House Members Want Third-party Food Audit Reforms
  • Jan 31,2012
    Frito-Lay Sued over 'All Natural' Claims for Corn Chips Derived from Biotech Ingredients
  • Jan 31,2012
    'All Natural' Class Action Litigation in California – Trend Will Continue in 2012
  • Jan 31,2012
    Product Recalls
  • Jan 31,2012
    USDA Clarifies Use of Vitamins and Minerals In Organic Foods and Infant Formulas
  • Jan 31,2012
    FTC Reaches $1.5 Million Settlement with Marketers Of Acai Berry and Colon Cleanser Products
  • Jan 31,2012
    Company Gets Warning Letter for Online Claims
  • More

FDA Regulation & Enforcement

  • Jun 26, 2020
    Feds Charge Regeneron with Providing Kickbacks Through Foundation Covering Medicare Co-pays
  • Jun 25, 2020
    AMS Proposes To Add Three Substances to Organic Substances List
  • Jun 24, 2020
    Supreme Court Decision on SEC Disgorgement May Lead to Limitations on the Remedy in FDA, FTC Actions
  • Jun 18, 2020
    Appeals Court Upholds Invalidation of Rule Requiring Price Disclosures in DTC TV Ads
  • Jun 17, 2020
    DOJ Intervenes in Qui Tam Suit Accusing Merit Medical Systems of Paying for Providers’ Advertising
  • Jun 12, 2020
    FDA Clarifies Policy on Distribution of Drug Samples During COVID-19 Pandemic
  • Jun 11, 2020
    California Diagnostic Test Company President Charged with Health Care, Securities Fraud
  • Jun 11, 2020
    Stakeholder Groups Seek Changes to FDA’s Food Standards of Identity
  • Jun 10, 2020
    Updated DOJ Guidance Provides Action Items for Corporate Personnel in Charge of Compliance Programs
  • Jun 8, 2020
    District Court Unseals Qui Tam Complaint Against Novo Nordisk over Promotion of Hemophilia Product
  • More

Medical Devices

  • Sep 29, 2014
    Court: FDA Lacks ‘Inherent Authority’ To Reclassify Device by Rescinding SE Decision
  • Sep 24, 2014
    FDA Workshop To Wrestle With Device Cybersecurity Issues; Agency Seeks ‘Whole of Community’ Approach
  • Sep 17, 2014
    District Court Refuses to Dismiss Claims That Relators Breached Nondisclosure Agreements
  • Sep 16, 2014
    FDA Will Survey Practitioners on Standardized Content, Format for Device Labeling
  • Sep 11, 2014
    Complaints Target Implant Manufacturer, Two Physician-owned Distributorships
  • Sep 9, 2014
    Staged Approvals Work Best for Pivotal Studies
  • Sep 5, 2014
    Smith & Nephew To Pay Over $8.3 Million To Resolve Allegations That It Violated Procurement Mandates
  • Sep 4, 2014
    ODE Director Moves to Job at FDA's Tobacco Center
  • Sep 4, 2014
    FDA Issues More UDI Guidance in Run-up to First Compliance Deadline; Lenses Given Extension
  • Sep 3, 2014
    DOJ Announces $2.6 Million Settlement With Spine Device Maker, Surgeon Over Alleged Kickbacks
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.